EMLAX | PELNX | EMLAX / PELNX | |
Total Expense Ratio | 1.10 | 2.17 | 51% |
Annual Report Gross Expense Ratio | 1.26 | 2.22 | 57% |
Fund Existence | 14 years | 7 years | - |
Gain YTD | 12.397 | 13.903 | 89% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 470M | 2.06B | 23% |
Annual Yield % from dividends | 4.56 | 6.78 | 67% |
Returns for 1 year | 11.86 | 14.92 | 80% |
Returns for 3 years | 28.95 | 41.07 | 70% |
Returns for 5 years | 13.54 | 24.90 | 54% |
Returns for 10 years | 23.58 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXP | 10.80 | 0.31 | +2.91% |
ProShares UltraShort FTSE China 50 | |||
MGOV | 20.06 | 0.11 | +0.53% |
First Trust Intermediate Gvt Opps ETF | |||
BSMR | 23.56 | 0.01 | +0.02% |
Invesco BulletShares 2027 Muncpl Bd ETF | |||
LIAO | 209.51 | N/A | N/A |
LifeX 2056 Infl-Prt Longevity Inc ETF | |||
BBEM | 58.16 | -0.12 | -0.21% |
JPMorgan BetaBuilders Emerging Mkt EqETF |